Charles Anthony Laranjeira - 04 Jun 2021 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Technical Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
04 Jun 2021
Net transactions value
-$129,215
Form type
4
Filing time
08 Jun 2021, 16:14:45 UTC
Next filing
11 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale $129,215 -2,117 -10% $61.04 18,681 04 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
F2 Includes 2 shares of common stock acquired under the issuer's employee stock purchase plan in December 2020.